Frank Value News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The growth in demand for appetite suppressing anti-obesity drugs like Novo Nordisk's Wegovy presents opportunities for food manufacturers and the market's initially downbeat reaction may be overdone, investors say. When Walmart said this month that it saw a slight pullback in food consumption when people took the medication, it sparked a sell off in shares of companies including Nestle, the world's biggest packaged food maker. "It feels like quite an overreaction," said Aviva portfolio manager Richard Saldanha.

The growth in demand for appetite suppressing anti-obesity drugs like Novo Nordisk's Wegovy presents opportunities for food manufacturers and the market's initially downbeat reaction may be overdone,...

(Bloomberg) -- Don’t belittle Corporate America’s famous profit engine.Most Read from BloombergUS Homeowners Are Tapping $9 Trillion in Real Estate WealthHistory Says It’s Time to Buy Long-Term Bonds as Peak Rates NearTop-Ranked Hedge Fund Chief Sees S&P 500 Entering ‘No Man’s Land’Tesla Starts Cybertruck Production Two Years Behind ScheduleBlackRock’s Rieder Says US Doesn’t Have to Fall Into RecessionEquity strategists are boosting earnings forecasts for the S&P 500 Index over the coming year f

For all the bank collapses, the plunging bond yields, the hammering in oil and mining stocks last week, US stocks actually rose. That’s a bullish signal says Adam Sarhan.

El acontecer de noticias nacionales, te lo traémos de primera mano en su Noticiero Venevision.